Belite Bio (BLTE) Reports In-Line Q4 EPS

Belite Bio (NASDAQ: BLTE) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Belite Bio, Inc, ADR (BLTE) PT Raised to $245 at H.C. Wainwright
• Robinhood (HOOD) call put ratio 3.5 calls to 1 put with a focus on September 11 weekly calls as share price up 2.3%
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings